Leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes.
Nanobiotix is a pioneering nanomedicine company focused on revolutionizing patient outcomes through innovative nanophysics-based approaches. Incorporated in 2003, Nanobiotix is dedicated to addressing unmet medical needs with highly effective and generalized solutions.
Nanobiotix's lead technology, NBTXR3, aims to enhance radiotherapy benefits for cancer patients. Additionally, the Immuno-Oncology program holds potential to transform cancer immunotherapies. The primary headquarters of Nanobiotix is located at 60, rue de Wattignies, Bat C, PARIS, 75012, FR.
Listed on Euronext Paris and Nasdaq Global Select Market, Nanobiotix continues to advance nanomedicine research and development. Nanobiotix is committed to expanding the boundaries of treatment possibilities. We invite the manager of Nanobiotix to create a customized and exclusive company showcase and product listing on our platform.
Nanobiotix est une entreprise pionnière dans le domaine de la nanomédecine, axée sur la révolution des résultats pour les patients grâce à des approches innovantes basées sur la nanophysique. Fondée en 2003, Nanobiotix se consacre à répondre aux besoins médicaux non satisfaits avec des solutions très efficaces et généralisées.
La technologie phare de Nanobiotix, NBTXR3, vise à améliorer les bénéfices de la radiothérapie pour les patients atteints de cancer. De plus, le programme d'immuno-oncologie a le potentiel de transformer les immunothérapies contre le cancer. Le siège principal de Nanobiotix est situé au 60, rue de Wattignies, Bat C, PARIS, 75012, FR.
Cotée sur Euronext Paris et le Nasdaq Global Select Market, Nanobiotix continue de faire progresser la recherche et le développement en nanomédecine. Nanobiotix s'engage à élargir les limites des possibilités de traitement. Nous invitons le responsable de Nanobiotix à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Compare Nanobiotix with 3 companies in Nanotechnology-Research
| Comparison Field |
NanobiotixMain Company |
UniTechLink Inc.View Profile |
Morgan Prestwich - L...View Profile |
PathosView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2010 | 2022 |
|
Company Size
|
— | 11-50 | 11-50 | 11-50 |
|
City
|
Vancouver , Massachusetts | Reigate, Surrey | Chicago, Illinois | |
|
Country
|
United States | United Kingdom | United States | |
|
Skills & Keywords
Comparing with main company
|
11 Total Skills
Nanomedicine
Nanotechnology
Radiotherapy
Immuno-Oncology
Cancer Treatment
Biotechnology
Pharmaceuticals
Nanoparticles
Pharma
Immuno-oncology
Oncology
|
7 Total
7 Unique
Unique Skills:
Bioinformatics
Cell Biology
Electrical engineering
IT
Mechanical Engineering
Organic chemistry
+1
|
53 Total
1 Common
52 Unique
Match
9%
Common Skills:
Pharmaceuticals
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
Cell Therapy
+46
|
11 Total
11 Unique
Unique Skills:
AI
Biopharma
Cancer Biology
Clinical Trials
Computational Biology
Data Science
+5
|
Other organizations in the same industry
This company is also known as